The prevalence of epilepsy in a rural district of Vietnam: A population‐based study from the EPIBAVI project

Tuấn, Nguyễn Anh; Cuong, Le Quang; Allebeck, Peter; Chúc, Nguyễn Thị Kim; Persson, Hans; Tomson, Torbjörn

doi:10.1111/j.1528-1167.2008.01663.x

Cited by 24 publications

(27 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The effect of concealment by women may be minimal, because this study was not based on self-reports but on medical records. This higher prevalence in men has also been found in the majority of European and North American studies (1), and has been reported in India (18) and Vietnam (19). On the other hand, a female predominance has been reported by many African and South American studies (1, 20).…”

Section: Discussionsupporting

confidence: 77%

Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data

Lee

Jung

Lee³

et al. 2012

J Korean Med Sci

View full text Add to dashboard Cite

The Korean national health security system covers the entire population and all medical facilities. We aimed to estimate epilepsy prevalence, anticonvulsant utilization pattern and the cost. We identified prevalent epilepsy patients by the prescription of anticonvulsants under the diagnostic codes suggesting seizure or epilepsy from 2007 Korean National Health Insurance databases. The information of demography, residential area, the kind of medical security service reflecting economic status, anticonvulsants, and the costs was extracted. The overall prevalence of treated epilepsy patients was 2.41/1,000, and higher for men than women. The age-specific prevalence was the lowest in those in their thirties and forties. Epilepsy was more prevalent among lower-income individuals receiving medical aid. The regional prevalence was the highest in Jeju Island and lowest in Ulsan city. New anticonvulsants were more frequently used than old anticonvulsants in the younger age group. The total annual cost of epilepsy or seizure reached 0.46% of total medical expenditure and 0.27% of total expenditure on health. This is the first nationwide epidemiological report issued on epilepsy in Korea. Epilepsy prevalence in Korea is comparable to those in developed countries. Economic status and geography affect the prevalence of epilepsy.

show abstract

Section: Discussionsupporting

confidence: 77%

Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data

Lee

Jung

Lee³

et al. 2012

J Korean Med Sci

View full text Add to dashboard Cite

show abstract

“…The prevalence rate of epilepsy in Vietnam is reported variously in studies as between 4.4–14 per 1000 of the population [20,21]. Treatment for epilepsy is provided through the National Mental Health Program; a vertical structure comprising four tiers of health care service at national, provincial, district and commune levels.…”

Section: Study Context Methods and Samplementioning

confidence: 99%

Multiple impacts of epilepsy and contributing factors: Findings from an ethnographic study in Vietnam

Aydemir

Trung

Snape

et al. 2009

Epilepsy & Behavior

View full text Add to dashboard Cite

We investigated issues related to treatment, impact of epilepsy, attitudes toward epilepsy and disclosure in Vietnam by using in depth interviews with people with epilepsy (PWE) and their family members. We found that although participants prefer Western treatment methods more than traditional ones, they experience problems in accessing different kinds of anti-epileptic drugs (AEDs) and higher-level treatment facilities and with respect to treatment expenses. The impact of epilepsy can be observed in a wide range of daily living activities which include working, education, marriage prospects and family formation. Although both families and society at large do not hold negative attitudes toward epilepsy, most PWE reported a sense of burden to others. Both PWE and family members generally prefer disclosing epilepsy rather than concealing it from others. Our findings strongly suggest a need for different types of AEDs, and supporting information for PWE, family members and general public about epilepsy.

show abstract

“…Approximately 4 billion people (50% of the global population) live in Asia, of whom about 23 million people live with epilepsy . The prevalence varies among Asian countries from 1.5 to 14.0 in 1000 (Table ) …”

Section: Burden Of Epilepsymentioning

confidence: 99%

Epilepsy in Asia: Disease burden, management barriers, and challenges

et al. 2018

View full text Add to dashboard Cite

This article reviews the burden of epilepsy in Asia, the challenges faced by people with epilepsy, and the management of epilepsy. Comparison is made with other parts of the world. For this narrative review, data were collected using specified search criteria. Articles investigating the epidemiology of epilepsy, diagnosis, comorbidities and associated mortality, stigmatization, and treatment were included. Epilepsy is a global health care issue affecting up to 70 million people worldwide. Nearly 80% of people with epilepsy live in low- and middle-income countries with limited resources. People with epilepsy are prone to physical and psychological comorbidities, including anxiety and depression, which can negatively impact their quality of life. Furthermore, people with epilepsy are at higher risk of premature death than people without epilepsy. Discrimination or stigmatization of people with epilepsy is common in Asia and can affect their education, work, and marriage opportunities. Access to epilepsy treatment varies throughout Asia. Although highly advanced treatment is available in some countries, up to 90% of people with epilepsy are not adequately treated or are not treated with conventional antiepileptic therapy in resource-limited countries. People in remote areas often do not receive any epilepsy care. First-generation antiepileptic drugs (AEDs) are available, but usually only in urban areas, and second-generation AEDs are not available in all countries. Newer AEDs tend to have more favorable safety profiles than first-generation AEDs and provide options to tailor therapy for individual patients, especially those with comorbidities. Active epilepsy surgery centers are present in some countries, although epilepsy surgery is often underutilized given the number of patients who could benefit. Further epidemiologic research is needed to provide accurate epilepsy data across the Asian region. Coordinated action is warranted to improve access to treatment and care.

show abstract

The prevalence of epilepsy in a rural district of Vietnam: A population‐based study from the EPIBAVI project

Cited by 24 publications

References 10 publications

Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data

Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data

Multiple impacts of epilepsy and contributing factors: Findings from an ethnographic study in Vietnam

Epilepsy in Asia: Disease burden, management barriers, and challenges

Contact Info

Product

Resources

About